Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem Laboratories LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511 India; Marketed by: Unichem Pharmaceuticals (USA), Inc ., Rochelle Park, NJ 07662; NDC 29300-113-05.
Published October 5, 2016 · Recall initiated: August 19, 2016
Summary
FDA records drug Class III recall D-1519-2016, published October 5, 2016 and initiated August 19, 2016. Recalling firm: Unichem Pharmaceuticals Usa Inc; Status: Terminated; Reported quantity: 368 bottles; Lot: Lot #: GLEH 16003, Exp 03/31/18. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if LAMOTRIGINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LAMOTRIGINE
- Manufacturer
- Unichem Pharmaceuticals Usa Inc
- Distributor
- Nationwide
- UPC
- 0329300113167
- Lot
- Lot #: GLEH 16003, Exp 03/31/18
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TNAugust 17, 2022
- FDALamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDCJune 10, 2020
- FDALamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd.February 19, 2020
- FDALamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For:September 26, 2018
- FDASennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FLOctober 5, 2016
- FDALifeCare PCA 3, PCA Serial List Number 12384 Allows for clinician administration or self-administration ofSeptember 28, 2016
Questions about this recall
Was Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem Laboratories LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511 India; Marketed by: Unichem Pharmaceuticals (USA), Inc ., Rochelle Park, NJ 07662; NDC 29300-113-05. recalled?
Yes. FDA published recall D-1519-2016 on October 5, 2016. Reported hazard: Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LAMOTRIGINE. UPC: 0329300113167.